- P-ISSN 2233-4203
- E-ISSN 2093-8950
- P-ISSN2233-4203
- E-ISSN2093-8950
- ESCI, SCOPUS, KCI
Article Detail
Home > Article Detail
Inhibitory Potential of Bilobetin Against CYP2J2 Activities in Human Liver Microsomes
Mass Spectrometry Letters / Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2020, v.11 no.4, pp.113-117
https://doi.org/10.5478/MSL.2020.11.4.113
(Kyungpook National University)
(BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
(BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
(BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
(BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
(BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
(BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
(BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
(BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit)
Wu,
Z., Jang,
S., Park,
S., Phuc,
N. M., &
Liu,
K.
(2020). Inhibitory Potential of Bilobetin Against CYP2J2 Activities in Human Liver Microsomes. Mass Spectrometry Letters, 11(4), 113-117, https://doi.org/10.5478/MSL.2020.11.4.113
- Downloaded
- Viewed
Abstract
Cytochrome P450 2J2 (CYP2J2) is a member of the cytochrome P450 superfamily, and is known to be arachidonic acid epoxygenase that mediates the formation of four bioactive regioisomers of epoxyeicosatrienoic acids (EETs). CYP2J2 is also involved in the metabolism of drugs such as albendazole, astemizole, danazol, ebastine, and terfenadine. CYP2J2 is highly expressed in the heart and cancer tissues. In this study, the inhibitory potential of ten natural products against CYP2J2 activity was evaluated using human liver microsomes and tandem mass spectrometry. Among them, bilobetin, which is a kind of biflavo-noid, exhibits a strong inhibitory effect against the CYP2J2-mediated astemizole O-demethylation (IC 50 = 0.73 µM) and terfena- dine hydroxylation (IC 50 = 0.89 µM). This result suggests that bilobetin can be used as strong CYP2J2 inhibitor in drug metabolism study.
- keywords
- bilobetin, CYP2J2, human liver microsomes, liquid chromatography-tandem mass spectrometry, natural products
- Submission Date
- 2020-12-13
- Revised Date
- 2020-12-29
- Accepted Date
- 2020-12-29
Other articles from this issue
- Advances in Ion Mobility Spectrometry-Mass Spectrometry (IMS-MS)-Based Techniques for Elucidating Higher-Order Protein Structures
- A Simple and Efficient Method to Determine Montelukast in Rat Plasma Using Liquid-Liquid Extraction and Tandem Mass Spectrometry
- Comparison of Matrices for Optimal Analysis of Synthetic Polymers Using MALDI-TOF Mass Spectrometry
- Simultaneous Determination of Anthraquinone, Flavonoids, and Phenolic Antidiabetic Compounds from Cassia auriculata Seeds by Validated UHPLC Based MS/MS Method
- Characterization of Natural Organic Matter in Spring Water
- A Low-Cost Open-Source Air Sampler for the Sorbent Tube Sampling for TD-GC/MS Analysis
- Chiral Derivatization of Hydroxycarboxylic Acids Using 2,4,6-Trichlorobenzoyl Chloride as a Highly Efficient Regioselective Esterification Reagent for Gas Chromatography-Mass Spectrometry
- Development of a Mushroom Powder Certified Reference Material for Element Analysis
- Inhibitory Potential of Bilobetin Against CYP2J2 Activities in Human Liver Microsomes
- Analysis of Hypoxia-Inducible Factor Stabilizers by a Modified QuEChERS Extraction for Antidoping Analysis
- more
Recommanded Articles
This website recommended the use the Chrome browser for journal website.